Aligos Therapeutics (ALGS)

• Market cap: $56.7M
• 1 day: 11.5%
• 5 days: 38.5%
• 1 month: -12.2%
• 3 months: -6.4%
• 6 months: 63.59%
• Year to date: -76.87%
• 1 year: -53.46%
• 5 years: -98.07%
• 10 years: -97.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70